Ondine Biomedical, Inc. OBI

Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF), the life sciences company, has secured the deployment of its Steriwave treatment across five hospitals in Southern Ontario. The hospitals, which serve a population of more than 3 million, will use the therapy to prevent infections in patients...

Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) President and CTO Nicolas Loebel spoke with Proactive's Stephen Gunnion about the company's photodisinfection technology, top-line results from its pivotal phase III LANTERN trial, and the commercial opportunity for Steriwave. The 5,188-patient phase III LANTERN study, conducted across 18 major US and Canadian hospitals, showed a 40.5% lower risk of 30-day surgical site infections. Loebel said the findings "change the entire nature of the company," highlighting a favourable safety profile with no device-related serious adverse events. He discussed the